Project Grant R01AI192792
Award Date 7/31/26
Completion Date 6/30/31
Dollars Obligated $722K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Stony Brook, NY 11794, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded The Research Foundation For The State University Of New York (operating as Stony Brook University) $466,199 on June 24, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the structural and mechanistic basis of lipid transport by the atypical membrane transporter RV1410C in Mycobacterium tuberculosis. The research uses cryo-electron microscopy and protein crosslinking in live cells to...
- The National Institute of Allergy and Infectious Diseases awarded The Research Foundation For The State University Of New York $161,774 on July 17, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research into cognate CD4+ T cell help to macrophages during tuberculosis infection. The funded research investigates molecular mechanisms by which CD4+ T cells engage macrophages to promote clearance of Mycobacterium tuberculosis from the lungs. The work will...
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University Of New York, operating as Stony Brook University, $432,892 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research into mycobacterial cell envelope organization and adaptation to environmental stress. The research program investigates how mycobacteria adapt their surface proteins, transport and modulate lipoproteins, and reorganize...
- The National Institute of Allergy and Infectious Diseases awarded The Research Foundation For The State University Of New York (operating as SUNY at Binghamton) $313,382 on July 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds characterization of a two-component regulatory system in Group B Streptococcus (GBS), focusing on environmental sensing and signal transduction through the SAERS system and characterization of the BVAP protein and its...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Stony Brook University a $3.13 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 23, 2025, with completion targeted for June 30, 2029. The grant funds research to develop new therapeutic strategies targeting STS-1 and STS-2 phosphatases as a means to enhance antimicrobial immune responses. The project deliverables include the identification...
- The National Institute of Allergy and Infectious Diseases awarded $787,580 to The Research Foundation For The State University Of New York, operating as Stony Brook University, on June 22, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research on polymicrobial tickborne infections, specifically studying how co-infections with Borrelia burgdorferi (Lyme disease) and Babesia microti (babesiosis) affect disease severity and immune response in an...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Research Foundation for the State University of New York (RF SUNY) a Project Grant of $437,895 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 14, 2025, with a completion date of June 30, 2027. The grant supports research to elucidate the mechanistic role of galectin-3-binding protein (LGALS3BP/90K) during severe acute respiratory syndrome coronavirus...
- The National Institute of Allergy and Infectious Diseases awarded The Research Foundation for the State University of New York $688,030 on July 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate SERINC5 regulation and its role in HIV-1 inhibition. The research examines mechanisms by which SERINC5, a host antiviral protein that potently inhibits HIV-1 infectivity, is regulated during retrovirus infection. The project investigates a novel...
- The National Institute of Allergy and Infectious Diseases awarded The Research Foundation for the State University of New York $199,524 on May 21, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the evolutionary origins of germinal center responses using genomic approaches. The research employs single-cell RNA sequencing and spatial transcriptomics to examine immune cell subsets and spatial organization in the spleen of the red-eared slider turtle...
- The National Institute of Allergy and Infectious Diseases awarded The Research Foundation For The State University Of New York $799,743 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop novel dual-acting therapeutics against multidrug-resistant and hypervirulent Klebsiella pneumoniae strains. The project targets the development of first-in-class, dual-acting anti-virulence antibiotics that address a critical gap in current treatment...